A web-based
Atlas
of
P
atient-
D
erived
X
enografts of cancer patients:A resource of MURAL PDX data
Home
Search
Search by IDs
Search by Gene
Browse
Plot Tool
With gene expression
Without gene expression
Mutation & CNV Plot
Annotation tool
Patient
Tumor & Clinical details
PDX & PDXBiomarker details
Update Data
View & Update
Statistics
Patient
Tumor details
Clinical details
PDX
Patient Number
*
PSA
*
Sex
*
Diagnosis
*
Return
Sample ID
*
Patient
*
---------
27
156
162
167
201
224
272
275
287
294
305
330
365
369
373
374
386
387
394
395
407
410
422
424
435
472
1001
1004
1007
1010
2000
3000
10002
175/382
197/238
426/452
455/463
Age Sample Collected
Age Sample Collected (binned in 5 year age groups
---------
20-24
25-29
30-35
35-39
40-44
45-49
50-54
55-59
60-64
65-69
70-74
75-80
Return
Sample
*
Sample site
Sample source
Pathology tumor diagnosis
Gleason score
Primary gleason index
Secondary gleason index
Tertiary gleason index
Isup grade group
Tumour grade
Damico risk classification
Tumour volume cc
Treatment prior to specimen collection
Return
Sample ID
*
---------
1001T
1004T
1007T
1010T
156R
162R
167.1R
167.2M
197M
201.1A
201.2A
224R
27.1A
27.2A
272R
275R
287R
294R
305R
330M
365R
369R
373M
374M
382M
386R
387.38A
394M
395M
407M
410.51A
422M
424M
426M
435.10A
435.1A
435.23A
435.31A
435.7A
452C
463.45A
463.55A
463.58A
463.8A
472M
PDX ID
*
PDX Host Type
PDX Graft Site
Current PDX Generation
*
Average PDX Generation Time (days ± SEM)
*
Tumor preparation2
*
Tumor characterization Technology
*
Tumor confirmed not to be of Mouse/EBV origin
*
Passage QA performed
*
PDX model availability
Host Strain (and Source)
*
Host Strain Immune system Humanised
*
---------
Yes
No
Pubmed ID
Governance restriction for distribution
Available to investigator
PDX Biomarker details
Markers AR
---------
Yes
No
Markers PSA
---------
Yes
No
Markers PSMA
---------
Yes
No
Markers NE
---------
Yes
No
Markers ERG
---------
Yes
No
Consistent with original
Return